Research on gene therapy, other products that specifically influence the functioning of the genetic material or a medicinal product with GMO

CCMO is the designated review committee for scientific research in which deliberately changes are made to the genetic material in human cells or the functioning of the genetic material is specifically being influenced. This is laid down in article 1, section a of the Central Review Decree (BCB) and the Explanatory Memorandum to the amended BCB.

CCMO is also the designated review committee for scientific research with a medicinal product that contains genetically modified organisms (GMO) as referred to in article 1.1 of the Genetically Modified Organisms (Environmental Management) Decree 2013. This is laid down in article 1, section f of the BCB.